Compare Abeona Therapeutics Inc (ABEO) vs Orion Office REIT Inc (ONL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Orion Office REIT Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Orion Office REIT Inc trades at $2.72 (market cap $158.01M). The key difference: Abeona Therapeutics Inc is far larger — about 2.7× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays a 2.89% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | ONL | |
|---|---|---|
Market Cap | $421.19M | $158.01M |
Sector | Health | Real Estate |
52-Week High | $7.45 | $3.04 |
52-Week Low | $4.17 | $1.93 |
Enterprise Value | $276.10M | $574.95M |
Dividend Yield | — | 2.89% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Orion Office REIT Inc
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →
